135 related articles for article (PubMed ID: 571143)
1. [Urinary cytology in tumors of the urinary tract].
Hüsermann M; Sommer E; Blumberg A
Schweiz Med Wochenschr; 1979 Mar; 109(9):304-8. PubMed ID: 571143
[TBL] [Abstract][Full Text] [Related]
2. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
3. [The value of urine sediment cytomorphology in the ambulatory differential diagnosis of hematuria].
Obroniecka I; Rojewska J; Wańkowicz Z
Pol Merkur Lekarski; 1998 Nov; 5(29):285-7. PubMed ID: 10101502
[TBL] [Abstract][Full Text] [Related]
4. Cytologic diagnosis of transitional cell carcinoma of the urinary bladder. Comparison with endoscopical and pathological findings on 538 cases.
Raica M; Minciu R; Miclea F; Botoca M; Drăgan P; Ioiart I
Rom J Morphol Embryol; 1997; 43(3-4):155-61. PubMed ID: 9747115
[TBL] [Abstract][Full Text] [Related]
5. Upper urinary tract washing in the diagnosis of transitional cell carcinoma of the renal pelvis and calices. A comparison with voided urine.
Raica M; Mederle O; Ioiart I
Rom J Morphol Embryol; 1995; 41(3-4):101-5. PubMed ID: 8772363
[TBL] [Abstract][Full Text] [Related]
6. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
7. [Urine cytology as a supplement to cystoscopy and biopsy in the control of bladder tumors].
Andersen OP; Ladefoged C; Røhl HF; Osther P; Holm K
Ugeskr Laeger; 1989 Dec; 151(50):3400-1. PubMed ID: 2609449
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of cytology of voided urine.
Koss LG; Deitch D; Ramanathan R; Sherman AB
Acta Cytol; 1985; 29(5):810-6. PubMed ID: 3863429
[TBL] [Abstract][Full Text] [Related]
9. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
10. [Value and limitations of urinary cytology in the diagnosis of bladder tumors].
Raica M; Ioan I
Acta Urol Belg; 1991; 59(4):133-47. PubMed ID: 1726382
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
Bergman J; Reznichek RC; Rajfer J
BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
[TBL] [Abstract][Full Text] [Related]
13. Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive?
Raitanen MP; Aine RA; Kaasinen ES; Liukkonen TJ; Kylmälä TM; Huhtala H; Tammela TL;
Scand J Urol Nephrol; 2002; 36(3):213-7. PubMed ID: 12201938
[TBL] [Abstract][Full Text] [Related]
14. Screening and monitoring for bladder cancer: refining the use of NMP22.
Ponsky LE; Sharma S; Pandrangi L; Kedia S; Nelson D; Agarwal A; Zippe CD
J Urol; 2001 Jul; 166(1):75-8. PubMed ID: 11435827
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of urinary cytology in bladder tumors--analysis of factors related with positivity of urinary cytology].
Tanaka K; Takashi M; Sahashi M; Shimoji T; Miyake K; Koshikawa T; Shiral T; Kawashima K; Nakajima N; Hamajima N
Hinyokika Kiyo; 1990 Jan; 36(1):7-11. PubMed ID: 1689930
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.
Nisman B; Barak V; Shapiro A; Golijanin D; Peretz T; Pode D
Cancer; 2002 Jun; 94(11):2914-22. PubMed ID: 12115379
[TBL] [Abstract][Full Text] [Related]
17. Clinical aspects of urinary cytology.
de Voogt HJ; Wielenga G
Acta Cytol; 1972; 16(4):349-51. PubMed ID: 4504236
[No Abstract] [Full Text] [Related]
18. Could nuclear matrix protein 22 (NMP22) play a role with urine cytology in screening for bladder cancer?--experience at Kuwait University.
Kapila K; Kehinde EO; Anim JT; Mojiminiyi OA; Vinsu A; George SS; Al-Maghrebi M; Al-Mulla F
Cytopathology; 2008 Dec; 19(6):369-74. PubMed ID: 18631356
[TBL] [Abstract][Full Text] [Related]
19. Exfoliative cytology of the urine in tumour diagnosis.
Puntala P; Koivuniemi A; Sivula A
Ann Chir Gynaecol Fenn; 1969; 58(1):20-3. PubMed ID: 5392146
[No Abstract] [Full Text] [Related]
20. Early results of bladder-cancer screening in a high-risk population of heavy smokers.
Steiner H; Bergmeister M; Verdorfer I; Granig T; Mikuz G; Bartsch G; Stoehr B; Brunner A
BJU Int; 2008 Aug; 102(3):291-6. PubMed ID: 18336612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
